Znanstveni rad - Izvorni znanstveni rad
Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials
Croatian Medical Journal, 51 (2010), 1; 61-73. https://doi.org/10.3325/cmj.2010.51.61


Citirajte ovaj rad

Trkulja, V. (2010). Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials. Croatian Medical Journal, 51. (1), 61-73. doi: 10.3325/cmj.2010.51.61

Trkulja, Vladimir. "Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials." Croatian Medical Journal, vol. 51, br. 1, 2010, str. 61-73. https://doi.org/10.3325/cmj.2010.51.61

Trkulja, Vladimir. "Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials." Croatian Medical Journal 51, br. 1 (2010): 61-73. https://doi.org/10.3325/cmj.2010.51.61

Trkulja, V. (2010) 'Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials', Croatian Medical Journal, 51(1), str. 61-73. doi: 10.3325/cmj.2010.51.61

Trkulja V. Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials. Croatian Medical Journal [Internet]. 15.02.2010. [pristupljeno 16.06.2024.];51(1):61-73. doi: 10.3325/cmj.2010.51.61

V. Trkulja, "Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials", Croatian Medical Journal, vol. 51, br. 1, str. 61-73, Veljača 2010. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:205213. [Citirano: 16.06.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.